Resilience-Building for Advance Care Planning
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT07428278
- Status
- Recruiting
Conditions
- Advanced Cancer
- End of Life
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- ROCKS — BEHAVIORALThe intervention will be provided to participants to strengthen optimism, communication skills, knowledge, and self-efficacy to support patients and family caregivers in engaging in advance care planning discussions.
- Usual Care — BEHAVIORALAn advance directive called Five Wishes will be provided to participants to increase their knowledge about advance care planning.
Study Details
The aims of this study are to (1) assess the feasibility, acceptability, and usability of the ROCKS intervention among patients with advanced cancer and their family caregivers through a randomized controlled trial in a cancer center setting; (2) evaluate the preliminary efficacy of ROCKS, as compared to usual care, on changes in completion of advance directives; and (3) explore the dyadic effects of resilience on self-efficacy, optimism, dyadic communication and coping, anxiety, and depression using an actor-partner interdependence model.
Key Dates
- Start date
- May 28, 2026
- Status verified
- Feb 2026
- Primary completion
- May 31, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 152 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: ROCKSParticipants assigned to this arm will receive a web-based resilience-building intervention.
- Active Comparator: Usual CareParticipants assigned to this arm will receive an advance directive called Five Wishes.
Primary Outcome Measure
Completion of advance directives [ Time Frame: Week 8 ]
Central Contacts
- Li-Ting Longcoy312-996-3024
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois Chicago | Chicago | Illinois | 60607 |
Find similar trials in Chicago, IL
By research site
Related Studies
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Artios Pharma Ltd · Birmingham, Alabama
- Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene InteractionsRecruiting · University of Chicago · Chicago, Illinois
- Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Qurient Co., Ltd. · Phoenix, Arizona
- A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815PHASE1 · Recruiting · Jazz Pharmaceuticals · Los Angeles, California